NCT04696965Completed
Appropriate Inhaler Use of Tiotropium As Add-on Therapy in Symptomatic Asthma
Appropriate Inhaler Use of Tiotropium As Add-on Therapy to Inhaled Glucocorticoids (ICS) with Long-acting Beta-agonists (LABA) in Adult Patients with Symptomatic Asthma: the Impact of Checking and Correcting Inhaler Technique in Real World
Source: ClinicalTrials.gov · Last updated 28 Feb 2025
Brief summary (registry, in English)
This pragmatic, two-arm, randomized controlled trial study aim to survey the inhaler errors of add-on tiotropium therapy with ICS+LABA in real-world practice of asthma patients and the efficacy of recheck stratage of inhaler skills. Patient characteristics and inflammatory features will be evaluated prospectively for association of asthma control by add-on tiotropium.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 23 Dec 2020
- Start date
- 4 Mar 2021
- Primary completion date
- 13 Mar 2023
- Lead sponsor
- Chang Gung Memorial Hospital
- Diseases
- Asthma
- NCT number
- NCT04696965
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 4 Mar 2021 to the primary completion date, 13 Mar 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with chronic obstructive pulmonary disease
Other
- Refuse to provide inform consent
- Pregnancy or breastfeeding women
- Using other Long-acting Muscarinic Antagonists e.g. Sebree, Ultibro, Anoro and Spiolto
Who the study is looking for
- Age 20 to 75 years old asthmatic patients under regular treatment
- Received medium to high dose ICS with LABA at least 3 months
- Persistent asthma related symptoms: asthma control questionnaire (ACQ-7\>1.5)
- Physicians in charged prescribed Tiotropium as add-on therapy according to clinical judgement.
Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Thoracic Medicine, Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.